Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Modeling for Chemical Research

By Drug Discovery Trends Editor | February 22, 2010

Accelrys, Inc. offers release of Materials Studio 5.0 a modeling and simulation platform for chemical and materials research. The new release includes integrated product enhancements ranging from advanced instrument simulation and visualization tools, to new and improved parallel codes. The updates deliver the performance and usability that today’s chemists, physicists and materials scientists need to increase research productivity and speed time-to-innovation, according to the company.  

“This product release furthers Accelrys’ commitment to delivering tools that not only streamline the scientific cycle, but also increase the relevance of scientific findings to business functions such as product engineering and design,” said Dr. Frank Brown, senior vice president and chief science officer at Accelrys. “With sophisticated tools for materials science research like Materials Studio 5.0, scientists can make breakthrough discoveries faster.”  

Providing a single, integrated platform for advanced modeling and simulation, Materials Studio enables scientists to more easily and efficiently perform highly complex research. Version 5.0 incorporates highly efficient parallel codes and supports a wider range of polymer and instrument simulations, delivering the industry’s fastest time-to-solution for sophisticated modeling tasks. The solution has already been proven in numerous research-driven industries, including pharmaceuticals.

Accelrys 

 

 


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE